MY POST ARE NOT ADVICE TO BUY/SELL/HOLD ANY STOCKS. Do your own DD before buying or selling in the STOCKMARKET
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Psychic Friends Network (PFNI)
--- Buying now here, I heard coming Big promotion in Wednesday..
The new “Bigger, Bolder, Better” commercials are the first in what PFN plans to be an intense six-month campaign re-introducing the brand in the public mindset. The original Psychic Friends Network brought in revenues of close to one billion dollars while establishing itself as what was considered the most popular infomercial of its time. The current campaign is scheduled to culminate with the first new full-length PFN infomercial in the first quarter of 2014.
$PFNI have a good plan..
Strong Buy $PFNI! time to hit more Higher price Today!
$PFNI -Looks Ready to Climb up at more higher Price!.
Hammer
Remember the Psychic Friends Network? The company rode the boom in infomercials in the early-1990s, $3.99/minute charges and Dionne Warwick’s mysterious allure to a $23 million profit in 1995. Three years and one Stephen Glass Harper’s feature later, the company filed for bankruptcy, claiming $1.2 million in assets against $26 million in liabilities.
Well, the future is back. According to an investor presentation filed with the Securities and the Exchange Commission yesterday, Psychic Friends Network is gearing up for a second act; in fact, PFN 2.0 is already in soft launch, with—pending a capital raise—a full marketing campaign planned for early next year. What’s more, the company is predicting an even rosier performance the second time around. Leveraging lower costs and greater reach made possible by the Internet, not to mention the current economic landscape (global turmoil=$$$), PFN’s financial soothsayers are prognosticating profits that put its earlier incarnation to shame, including projected income of $64 million in 2015.
Early Birds always get the worm!
Buy now before $XTRM go more HIGH!!
Keep buying for more Bounce Up!!
Load more only 5% Down.. lets back it Up!!
$PFNI - Hammer
lets move FORWARD!!
$XTRM - HAMMER
I dont think so, early birds get's the worm!!
Good start here to Buy!! this will be promoted soon.. Stay here Buy now!!
Load more good things Coming $XTRM..
Keep going More buy $PLPL!!
More buying. Looks $IOGA starting to heat up again..
Good Start $IOGA - Ready to print High Price!!.
Hammer
Looks nice $PLPL!!
Hammer!
$IOGA Looks easy to Bounce up more High Price today!!
Form 10-Q for PLANDAI BIOTECHNOLOGY, INC.
Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This statement includes projections of future results and "forward looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this Quarterly Report, other than statements of historical fact, are forward looking statements. Although management believes that the expectations reflected in these forward looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.
BUSINESS
Planda? Biotechnology, Inc., (the "Company") through its recent acquisition of Global Energy Solutions, Ltd. and its subsidiaries, focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa.
The Company was incorporated, as Jerry's Inc., in the State of Florida on November 30, 1942. The company catered airline flights and operated coffee shops, lounges and gift shops at airports and other facilities located in Florida, Alabama and Georgia. The company's airline catering services included the preparation of meals in kitchens located at, or adjacent to, airports and the distribution of meals and beverages for service on commercial airline flights. The company also provided certain ancillary services, including, among others, the preparation of beverage service carts, the unloading and cleaning of plates, utensils and other accessories arriving on incoming aircraft, and the inventory management and storage of airline-owned dining service equipment. In March of 2004 we moved our domicile to Nevada and changed our name to Diamond Ranch Foods, Ltd. Diamond Ranch Foods, Ltd. was engaged in the meat processing and distribution industry. Operations consisted of packing, processing, custom meat cutting, portion controlled meats, private labeling, and distribution of our products to a diversified customer base, including, but not limited to; in-home food service businesses, retailers, hotels, restaurants and institutions, deli and catering operators, and industry suppliers. On November 17, 2011, the Company, through its wholly-owned subsidiary, Planda? Biotechnologies, Inc. consummated a share exchange with Global Energy Solutions Corporation Limited, an Irish corporation. Under the terms of the Share Exchange, GES received 76,000,000 shares of Diamond Ranch that had been previously issued to Planda? Biotechnologies, Inc. in exchange for 100% of the issued and outstanding capital of GES. On November 21, 2011, the Company filed an amendment to the articles of incorporation to change the name of the company to Planda? Biotechnology, Inc.
We will continue to seek to raise additional capital through the sale of common stock to fund the expansion of our company. There can be no assurance that we will be successful in raising the capital required and without additional funds we would be unable to expand our plant, acquire other companies, or further implement our business plan. In April 2012, through our subsidiary companies, we secured a 100 million Rand (approximately $13 million) financing with the Land and Agriculture Bank of South Africa which will be used to build infrastructure and further operations.
PRODUCTS AND SERVICES
Planda? Biotechnologies has a proprietary technology that extracts a high level of bio-available compounds from organic matter including green tea leaves and most other organic materials. Numerous documented scientific studies have been conducted over the past ten years using this technology that releases bioavailable antioxidants and other phytonutrients in form the body can easily absorb.The Company intends to use its notarial leases to focuses on the farming of whole fruits, vegetables and live plant material and the production of Phytofare? functional foods and botanical extracts for the health and wellness industry using its proprietary extraction technology.
The company is presently developing for market two unique extracts: Phytofare? Green Tea Catechin Extract and Phytofare? Citrus Limonoid Glycoside Complex.
COMPETITION
The Company faces competition from a variety of sources. There are several large producers of farm products including green tea and there are numerous companies that develop and market nutraceutical products that include bio-available compounds including those from green tea extract. Many of these competitors benefit from established distribution, market-ready products, and greater levels of financing. Planda? intends to compete by producing higher quality and higher concentration extracts, producing at lower costs, and controlling a vertically integrated market that includes all stages from farming through production and marketing.
CUSTOMERS
Planda? will market to end users as well as other nutraceutical companies that require high-quality bio-available extracts for their products. In addition, the Company anticipates having surplus farm products including avocado, and macadamia nuts.
SALES
For the three months ended September 30, 2013, revenues were $226,953 compared to revenues of $90,785 for the quarter ended September 30, 2012. Sales consisted of avocados, macadamia nuts and timber from the company's tea estate in South Africa. The company also recorded revenues of $196,906 from the sale of a license agreement. Sales of Phytofare? extracts are not expected to commence until Summer 2013, when the commercial-grade extraction facility is completed.
Cost of sales for the quarter ended September 30, 2013 was $135,397, which consists of expenses incurred with managing and restoring the Senteeko Tea Estate. There were no such costs associated in the prior year as the company had not yet begun rehabilitating the property and therefore no associated farming costs. A third party harvested the fruit and timber and paid the company a fixed price per unit.
EXPENSES
Our total expenses for the three months ended September 30, 2013 were $537,907 compared to $496,146 for the same period of the prior year. Expenses in 2013 consisted primarily of salaries, rent, professional services and general and administrative expenses. Expenses were comparable from year to year with the exception of rent expense, which did not exist in 2012, and a reduction in professional services from 2012 to 2013.
LIQUIDITY AND CAPITAL RESOURCES
For the three months ended September 30, 2013, the Company's cash used in operating activities totaled $581,340, which was primarily attributable to a loss from operations, and cash used in investing activities was $440,748, which consisted of the purchase of fixed assets to be used in production. Cash provided by financing activities was $898,758, generated by draw downs on the loan from the Land and Agriculture Bank of South Africa and borrowings of $125,000 under convertible notes. As of September 30, 2013, the Company had current assets of $453,832 compared to current liabilities of $819,731.
PLAN OF OPERATION
The Company's long-term existence is dependent upon our ability to execute our operating plan and to obtain additional debt or equity financing to fund payment of obligations and provide working capital for operations. In April 2012, the Company through majority-owned subsidiaries of Dunn Roman Holdings Africa (Pty) Limited , executed final loan documents on a 100 million Rand (approx. $13 million USD) financing with the Land and Agriculture Bank of South Africa and has begun rehabilitating the Senteeko Tea Estate so that it can begin yielding green tea feedstock by the end of 2013. The company has also commenced construction of the factory and associated equipment necessary to begin the extraction process on live botanical matter, including green tea and citrus, with a goal to have the factory completed by the end of 2013. Once the facility is tested and operational, the company will commence processing green tea material for its Phytofare? Catechin Complex in the first quarter of 2014.
CRITICAL ACCOUNTING POLICIES
The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. While there are a number of significant accounting policies affecting our financial statements, we believe the following critical accounting policies involve the most complex, difficult and subjective estimates and judgments.
Revenue recognition
The Company derives its revenue from the production and sale of farm goods, raw materials and the sale of bioavailable extracts in both raw material and finished product form. Revenues are recognized when product is ordered and delivered. Product shipped on consignment is not counted in revenue until sold.
Intangible and Long-Lived Assets
We follow Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 360, "Property Plant and Equipment", which establishes a "primary asset" approach to determine the cash flow estimation period for a group of assets and liabilities that represents the unit of accounting for a long lived asset to be held and used. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.
Goodwill is accounted for in accordance with ASC Topic 350, "Intangibles - Goodwill and Other". We assess the impairment of long-lived assets, including goodwill and intangibles on an annual basis or whenever events or changes in circumstances indicate that the fair value is less than its carrying value. Factors that we consider important which could trigger an impairment review include poor economic performance relative to historical or projected future operating results, significant negative industry, economic or company specific trends, changes in the manner of our use of the assets or the plans for our business, market price of our common stock, and loss of key personnel. We have determined that there was no impairment of goodwill during 2013 or 2012. The share exchange did not result in the recording of goodwill and there is not currently any goodwill recorded.
Potential Derivative Instruments
We periodically assess our financial and equity instruments to determine if they require derivative accounting. Instruments which may potentially require derivative accounting are conversion features of debt and common stock equivalents in excess of available authorized common shares.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
Non-Controlling Interest
Planda? owns 82% of Dunn Roman Holdings-Africa, which in turn owns 74% each of Breakwood Trading 22 (Pty, Ltd. and Green Gold Biotechnologies (Pty), Ltd., in order to be compliant with the Black Economic Empowerment rules imposed by the South African Land Bank. While the Company, under the Equity Method of Accounting, is required to consolidate 100% of the operations of its majority-owned subsidiaries, that portion of subsidiary net equity attributable to the minority ownership, together with an allocated portion of net income or net loss incurred by the subsidiaries, must be reflected on the consolidated financial statements. On the balance sheet, minority interest has been shown in the Equity Section, separated from the equity of Planda?, while on the income statement, the non-controlling shareholder allocation of net loss has been shown in the Consolidated Statement of Operations.
Currency Translation Adjustment
The Company maintains significant operations in South Africa, where the currency is the Rand. The subsidiary financial statements are therefore converted into US dollars prior to consolidation with the parent entity, Planda? Biotechnology, Inc. US GAAP requires that the weighted average exchange rate be applied to the foreign income statements and that the closing exchange rate as of the period end date be applied to the balance sheet. The cumulative foreign currency adjustment is included in the equity section of the balance sheet.
http://biz.yahoo.com/e/131119/plpl10-q.html
Nice $PLPL Back to Up!!
Hammer!!
Bottom line!! BUY $PLPL Now before any promotion Comes!, Make it green
PLPL
INSCOR, Inc.’s New CEO Generating Big Revenues in Creative Ways
It has been just over a month since INSCOR, Inc. (OTC PINK: IOGA) named Kenny Andam as its new Chief Executive Officer (CEO), but what a month it has been. In that short time, the new CEO landed the company squarely in the middle of negotiations with an organization in his homeland of Ghana and walked away with a very lucrative insurance deal. INSCOR and the National Mass Social Welfare Scheme in Ghana (MSWS) hammered out a deal that has INSCOR insuring lost or stolen welfare cards that will be issued to MSWS’s members.
For INSCOR, this represents approximately $3 million in gross monthly revenue beginning November 30, 2013, and ultimately rising to $18 million in estimated gross monthly revenue within three years of the launch of the cards. So, some quick math should make any investor giddy at the company’s current price tag, as you realize that securing this contract means $36 million per year in gross revenues as coverage on the cards kicks in beginning this November.
That gross revenue quickly grows to over $200 million each year by the third year when MSWS ramps up coverage to all 18 million of its members in Ghana. And, the good doesn’t stop there! The company can continue to capitalize with MSWS’s growth, which is projected to reach 650 million subscribers to its programs throughout Africa by 2030.
With revenues scheduled to roll in this month and limitless potential, there could not be a better time jump on board.
Much better to load now before it happen! Bounce up to higher prize will surely print Soon!!
Strong Buy $PLPL
PLPL Bounce Report
Plandai Biotechnology, Inc. Expects to Head into Q4 2013 and 2014 Moving from Solely a R&D Biotech to the Marketplace
Plandai Biotechnology, Inc. (OTCBQ: PLPL) has reported it should be producing Phytofare Catechin Complex at its Senteeko facility beginning in January 2014. After production, the product will be shipped to the Pheroid production facility in South Africa for further processing. Plandaí says the Phytofare / Pheroid product will then be further tested to make sure it conforms to the standard profile, and then the company can release it to market.
Executives estimate that by March 1, 2014, all testing will be complete and product will be ready to ship to customers in four different formulations:
1. Phytofare™ Catechin Complex – This is a water-soluble powder.
2. Ph2™ Topical Catechin Complex – This is a topical cream that has Phytofare nano-entrapped in Pheroid.
3. Ph2™ Oral Catechin Complex – This is a gel tab version of Phytofare nano-entrapped in Pheroid, suitable for oral consumption.
4. Ph2™ Liquid Catechin Complex – This is an oral version of Phytofare nano-entrapped in Pheroid in a liquid suspension, suitable for mixing into beverages and liquid medications.
Once sales commence in early 2014, Plandaí will move directly into the next phase of operations, which the company says primarily consists of actively pursuing drug targets for Phytofare™ and the development of additional products.
Plandai Biotechnology, Inc. Adds Pheroid™ Technology to Strengthen Products
Plandai Biotechnology Inc. (OTCQB: PLPL) already has a technology in place with its hydrodynamic sheering process that is allowing it to boast of higher bioavailability with its Phytofare™ products than other nutraceutical producers in the industry; however, the company isn’t stopping there and has entered into an exclusive license agreement that allows it the use of Pheroid™ technology - a deal that makes its products even stronger than first reported.
Plandai continues its pursuit to bring products to the marketplace that can benefit its users with much higher absorption rates, and to that end, the addition of the Pheroid technology should dramatically enhance its products. The Pheroid technology is an encapsulation or entrapment based technology that encases the target material inside of a long-chain fatty acid.
Plandai obviously jumped at the opportunity to add this technology to its work with botanicals because it will serve two purposes en route to improving bioavailability. The benefit to Plandai and its customers is that by using the Pheroid technology, it will allow the company to get its Phytofare™ molecules to the target tissues undamaged which, in turn, promotes greater absorption.
This only repost:
$PLPL
agree. anytime will Bounce up $PLPL!! i see this stock alerted in FB. Twitter.. good things coming this week!!
Grab full info $IOGA here,http://ddnotesmaker.com/index.php?ticker=ioga Remember Early Birds always Catch the Worm!!.
Load now for the higher Price!! Good things coming this week!!
More buys $PLPL lets move to High Price!!
$PLPL Looks Great more Higher price will print soon!! Hammer!!
Load now before the ALL eye's Come's!! higher Price will print Soon!!
starting to heat up again $IOGA ready to move up. Higher Price will Print Soon!! Loading!!
News out $IOGA' Get Ready for the Bounce
Hammer
Great News Out* Plandai Biotechnology, Inc. (PLPL) The company's Phytofare™ Catechin Complex is one of the candidates that Plandaí feels can make a difference in the ongoing battle to control diabetes. In the IDF's report it stated that worldwide 382 million people live with diabetes which is up from 285 million just four short years ago. According to the IDF, there are no signs of slowing as the number of people affected by the disease is expected to climb 55 percent to 592 million by 2035.
These dismal numbers don't include the many millions of undiagnosed cases around the world which is equally as troubling. Annual healthcare spending for diabetes is estimated to be $548 billion by the IDF, and as soon as 2018, the annual market for diabetes drugs and devices alone is projected to reach over $114 billion worldwide
$PLPL - Strong Buy for the Bounce up
there's a chance for the bounce Up $IOGA this week.. :) its up to you!!
Buy now $PLPL for the Possible move high this Week
http://scharts.co/18ivp67 Load!Load!
$IOGA
Loading $PLPL! Power hour will come.. Be ready
This is it.. $IOGA is ready to Move Up!!!Hammer
Looking for Power Hour $IOGA - Hammer! Buy!
more buy's $PLPL lets Move up.